• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

持续加强 FDA 对新兴技术的科学方法。

Continuing to strengthen FDA's science approach to emerging technologies.

机构信息

Emerging Technology Programs, Office of the Commissioner, Food and Drug Administration, Silver Spring, MD, USA.

出版信息

Nanomedicine. 2013 Jul;9(5):594-9. doi: 10.1016/j.nano.2013.04.005. Epub 2013 May 18.

DOI:10.1016/j.nano.2013.04.005
PMID:23692697
Abstract

Emerging technologies result when advances and innovation in technology lead to discoveries. Often emerging technologies stimulate novel research in medical product development that contribute to new approaches to manufacturing and can improve the quality of products. By supporting investments in agency coordination, staff training and professional development, regulatory science research, stakeholder engagement, and enhancing opportunities for expert input, the U.S. Food and Drug Administration plays a critical role in translating innovations into novel safe and effective medical products that improve the public health.

摘要

新兴技术是科技进步和创新带来的发现。新兴技术通常会激发医学产品开发方面的新颖研究,为制造提供新方法,并提高产品质量。通过支持机构协调、人员培训和专业发展、监管科学研究、利益相关者参与以及增加专家意见的机会,美国食品和药物管理局在将创新转化为新颖的安全有效的医疗产品以改善公众健康方面发挥着至关重要的作用。

相似文献

1
Continuing to strengthen FDA's science approach to emerging technologies.持续加强 FDA 对新兴技术的科学方法。
Nanomedicine. 2013 Jul;9(5):594-9. doi: 10.1016/j.nano.2013.04.005. Epub 2013 May 18.
2
FDA and the critical path to twenty-first-century medicine.
J Med Philos. 2008 Oct;33(5):515-23. doi: 10.1093/jmp/jhn021.
3
Science and regulation. FDA's approach to regulation of products of nanotechnology.科学与监管。美国食品药品监督管理局对纳米技术产品的监管方法。
Science. 2012 Apr 20;336(6079):299-300. doi: 10.1126/science.1205441.
4
Transforming regulatory science 2012: making a difference.2012 年监管科学改革:发挥作用。
Clin Pharmacol Ther. 2012 Mar;91(3):375-7. doi: 10.1038/clpt.2011.329.
5
Advancing pharmaceutical quality: An overview of science and research in the U.S. FDA's Office of Pharmaceutical Quality.推进药物质量:美国 FDA 药品质量办公室的科学与研究概述。
Int J Pharm. 2016 Dec 30;515(1-2):390-402. doi: 10.1016/j.ijpharm.2016.10.038. Epub 2016 Oct 20.
6
FDA's expanding postmarket authority to monitor and publicize food and consumer health product risks: the need for procedural safeguards to reduce "transparency" policy harms in the post-9/11 regulatory environment.美国食品药品监督管理局扩大上市后监管权限以监测并公布食品及消费品健康风险:在9·11后的监管环境中,需要程序保障措施来减少“透明度”政策带来的危害
Food Drug Law J. 2009;64(3):577-98.
7
The role of the FDA in the effort against AIDS.美国食品药品监督管理局在抗击艾滋病行动中的作用。
Public Health Rep. 1988 May-Jun;103(3):242-5.
8
Export of pharmaceuticals and medical devices under the federal Food, Drug & Cosmetic Act: FDA's striking change in interpretation post-Shelhigh.根据联邦《食品、药品和化妆品法案》进行的药品和医疗器械出口:谢尔希案后美国食品药品监督管理局在解释上的显著变化。
Food Drug Law J. 2009;64(1):149-69.
9
Impact of regulatory science on global public health.监管科学对全球公共卫生的影响。
Kaohsiung J Med Sci. 2012 Jul;28(7 Suppl):S5-9. doi: 10.1016/j.kjms.2012.05.003. Epub 2012 Jul 10.
10
Regulatory research. A centennial letdown for FDA's biologics group.监管研究。美国食品药品监督管理局生物制品部门的百年遗憾。
Science. 2002 Nov 29;298(5599):1704-5. doi: 10.1126/science.298.5599.1704.

引用本文的文献

1
Parent and professional perspectives on behavioral inflexibility in autism spectrum disorders: A qualitative study.自闭症谱系障碍中行为灵活性的家长和专业人士观点:一项定性研究。
Autism. 2019 Jul;23(5):1236-1248. doi: 10.1177/1362361318810217. Epub 2018 Nov 3.
2
Concise Review: The U.S. Food and Drug Administration and Regenerative Medicine.简明综述:美国食品药品监督管理局与再生医学
Stem Cells Transl Med. 2015 Dec;4(12):1495-9. doi: 10.5966/sctm.2015-0098. Epub 2015 Oct 22.
3
New agents for the treatment of lymphoid leukemia and lymphoma: focus on recent FDA approvals.
治疗淋巴白血病和淋巴瘤的新型药物:聚焦美国食品药品监督管理局近期批准的药物
Discoveries (Craiova). 2014 Jan-Mar;2(1). doi: 10.15190/d.2014.6.